Difficulty: Medium
Average Score: 73%
Practice
Which of the following is a first-line treatment for juvenile idiopathic arthritis?
Correct answer
A
Rationale
In pediatric nursing, the first-line treatment for juvenile idiopathic arthritis is typically NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) like ibuprofen or naproxen. NSAIDs are preferred due to their effectiveness in reducing pain and inflammation in children with arthritis. They are considered safer than other options for initial treatment in this population.
Biologics (Option B) are often used if NSAIDs are ineffective or if the disease is more severe. These medications target specific components of the immune system involved in the inflammatory process. However, they are usually reserved for cases that do not respond to NSAIDs.
Corticosteroids (Option C) may be used in some cases to quickly reduce inflammation and pain, but their long-term use in children is associated with significant side effects. Therefore, they are not typically recommended as the first-line treatment.
DMARDs (Disease-Modifying Anti-Rheumatic Drugs) (Option D) are more commonly used in adults with arthritis, and their use in children is limited due to safety concerns and the availability of other effective options.
Educationally, understanding the rationale behind the choice of NSAIDs as the first-line treatment for juvenile idiopathic arthritis is crucial for pediatric nurses. It ensures safe and effective management of this chronic condition in children. Nurses must be aware of the indications, contraindications, and potential side effects of different treatment options to provide comprehensive care to pediatric patients with arthritis.
Biologics (Option B) are often used if NSAIDs are ineffective or if the disease is more severe. These medications target specific components of the immune system involved in the inflammatory process. However, they are usually reserved for cases that do not respond to NSAIDs.
Corticosteroids (Option C) may be used in some cases to quickly reduce inflammation and pain, but their long-term use in children is associated with significant side effects. Therefore, they are not typically recommended as the first-line treatment.
DMARDs (Disease-Modifying Anti-Rheumatic Drugs) (Option D) are more commonly used in adults with arthritis, and their use in children is limited due to safety concerns and the availability of other effective options.
Educationally, understanding the rationale behind the choice of NSAIDs as the first-line treatment for juvenile idiopathic arthritis is crucial for pediatric nurses. It ensures safe and effective management of this chronic condition in children. Nurses must be aware of the indications, contraindications, and potential side effects of different treatment options to provide comprehensive care to pediatric patients with arthritis.